These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8097673)

  • 1. A newly synthesized bifunctional inhibitor, W-77, enhances adriamycin activity against human ovarian carcinoma cells.
    Maeda O; Terasawa M; Ishikawa T; Oguchi H; Mizuno K; Kawai M; Kikkawa F; Tumoda Y; Hidaka H
    Cancer Res; 1993 May; 53(9):2051-6. PubMed ID: 8097673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A newly synthesized bifunctional inhibitor, CKA1083, enhances adriamycin activity against human ovarian carcinoma cells.
    Maeda O; Kikkawa F; Tamakoshi K; Obata NH; Mizuno K; Suganuma N; Tomoda Y; Kuzuya K; Ishikawa T; Hidaka H
    Anticancer Res; 1997; 17(3C):1985-92. PubMed ID: 9216655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
    Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
    Moscow JA; Townsend AJ; Cowan KH
    Mol Pharmacol; 1989 Jul; 36(1):22-8. PubMed ID: 2747627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
    Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
    Zhang T; Guan M; Jin HY; Lu Y
    Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The expression of GST pi mRNA in the P388/ADR and L1210/DDP resistant lines examined by synthetic probe].
    Liu YB
    Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):264-7. PubMed ID: 8174463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and-resistant human ovarian carcinoma cells.
    Oguchi H; Kikkawa F; Kojima M; Maeda O; Mizuno K; Suganuma N; Kawai M; Tomoda Y
    Anticancer Res; 1994; 14(1A):193-200. PubMed ID: 7909418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of MDR1, GST-pi and topoisomerase II as an indicator of clinical response to adriamycin.
    Kim R; Hirabayashi N; Nishiyama M; Saeki S; Toge T; Okada K
    Anticancer Res; 1991; 11(1):429-31. PubMed ID: 1850221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization of resistance to mitoxantrone and adriamycin in Caco-2 human colon adenocarcinoma cells: a possible role for glutathione S-transferases.
    Peters WH; Roelofs HM
    Cancer Res; 1992 Apr; 52(7):1886-90. PubMed ID: 1348015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells.
    Kotoh S; Naito S; Yokomizo A; Kumazawa J; Asakuno K; Kohno K; Kuwano M
    Cancer Res; 1994 Jun; 54(12):3248-52. PubMed ID: 8205547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione S-transferase and glutathione peroxidase are essential in the early stage of adriamycin resistance before P-glycoprotein overexpression in HOB1 lymphoma cells.
    Lee WP; Lee CL; Lin HC
    Cancer Chemother Pharmacol; 1996; 38(1):45-51. PubMed ID: 8603451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of cytosolic glutathione S-transferases in drug-resistant L5178Y murine lymphoblasts: chemical selectivity and molecular mechanisms.
    Stelmack GL; Goldenberg GJ
    Cancer Res; 1993 Aug; 53(15):3530-5. PubMed ID: 8101761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterization of two distinct adriamycin-resistant sublines from LoVo human colon carcinoma cells.
    Yang LY; Trujillo JM; Su YZ
    Anticancer Res; 1992; 12(2):473-9. PubMed ID: 1349796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
    Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glutathione S transferases-pi].
    Takahashi Y; Niitsu Y
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):945-51. PubMed ID: 8002632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione derivatives enhance adriamycin cytotoxicity in a human lung adenocarcinoma cell line.
    Nakanishi Y; Matsuki H; Takayama K; Yatsunami J; Kawasaki M; Abe M; Hara N
    Anticancer Res; 1997; 17(3C):2129-34. PubMed ID: 9216676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of KN-62, Ca2+/calmodulin-dependent protein kinase II inhibitor, on adriamycin resistance of human ovarian cancer cells.
    Obata NH; Okazaki K; Maeda O; Kikkawa F; Tomoda Y; Hidaka H
    Biochem Biophys Res Commun; 1995 Oct; 215(2):566-71. PubMed ID: 7487993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning and characterization of the complementary DNA for the M(r) 85,000 protein overexpressed in adriamycin-resistant human tumor cells.
    Sugimoto Y; Hamada H; Tsukahara S; Noguchi K; Yamaguchi K; Sato M; Tsuruo T
    Cancer Res; 1993 Jun; 53(11):2538-43. PubMed ID: 8495417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.